Assessment of phototoxicity in pigmented Long-Evans rat: sparfloxacin and 8-methoxypsoralen

Regul Toxicol Pharmacol. 2018 Feb:92:303-314. doi: 10.1016/j.yrtph.2017.11.014. Epub 2017 Nov 28.

Abstract

The aim of the present work was to evaluate the effects of photo-activated toxicity induced after administration of two known melanin-binding phototoxic compounds, sparfloxacin (SPX) and 8-methoxypsoralen (8-MOP), followed or not by UVA/Vis exposure, in pigmented rats (Long Evans: LE) and albino rats (Sprague Dawley: SD). Groups of three rats were treated with SPX or 8-MOP by oral gavage for six consecutive days. Irradiated animals were submitted to a UVA/Vis light dose standardized to 10 J/cm2 UVA daily. Clinical signs, cutaneous reactions and body weight were monitored throughout the study period. Ear biopsy weight, lymph node weight and lymph node cell count were determined at necropsy. Ophthalmologic examinations were performed before the first treatment and on the day of sacrifice. Microscopic examinations were performed on skin biopsies and eyes. Phototoxicity was demonstrated for both SPX and 8-MOP in the pigmented and albino strains, in terms of auricular irritation, lymph node weight and proliferation index, cutaneous reactions and ocular histopathology. LE rats were less sensitive than SD rats, especially at the ocular level, supporting the notion that pigmentation may provide protection against photo-activation. The pigmented rat may be a more relevant model than the albino rat for human safety evaluation.

Keywords: Melanin-binding; Photo-activation; Photosafety; Pigmentation; Rats; UVA/Vis irradiation.

MeSH terms

  • Animals
  • Cell Proliferation / drug effects
  • Dermatitis, Phototoxic / etiology*
  • Eye / drug effects
  • Female
  • Fluoroquinolones / adverse effects*
  • Lymph Nodes / drug effects
  • Methoxsalen / adverse effects*
  • Pigmentation / drug effects*
  • Rats
  • Rats, Long-Evans
  • Rats, Sprague-Dawley
  • Skin / drug effects
  • Ultraviolet Rays / adverse effects

Substances

  • Fluoroquinolones
  • sparfloxacin
  • Methoxsalen